Back to Peptide Pedia
Immune & Vitality
Emerging Research

KPV

KPV

Anti-inflammatory tripeptide.

Also known as: Lysine-Proline-Valine, α-MSH(11-13)

Research dose range200–500 mcg daily (research models)
Route studiedSubcutaneous / oral / topical
Study durationDaily, multi-week studies
Storage2–8 °C reconstituted

Overview

KPV is a tripeptide fragment of alpha-MSH studied in anti-inflammatory and gut-health research models.

Key research findings

The C-terminal tripeptide of alpha-MSH (Lys-Pro-Val), studied for potent anti-inflammatory activity without the pigmentation effects of full alpha-MSH. Research focuses on gut inflammation (IBD models) and skin, where it can act both systemically and topically.

Mechanism of action

Studied for entering cells and modulating inflammatory signaling (NF-kB pathway) without the pigmentary effects of full alpha-MSH.

Molecular information

Weight342.4 Da
Length3 amino acids
TypeAlpha-MSH C-terminal tripeptide
Amino-acid sequenceLys-Pro-Val

The minimal anti-inflammatory fragment of alpha-MSH, lacking melanocortin pigment activity.

Pharmacokinetics

Peak: ~1 hourHalf-life: ~Short (hours)Cleared: ~24 hours
Peak · 1hHalf-life · 5h

Illustrative relative-concentration model derived from published pharmacokinetic research. Curve is normalized and provided for educational comparison only — not a dosing schedule.

Research applications

  • Anti-inflammatory research
  • Gut-health studies
  • Immune-modulation investigations

Research protocols

Protocols summarized from published research models. Provided for scientific reference only — not dosing guidance for human use.

Systemic referenceAmount: 200–500 mcgFrequency: Once dailyRoute: Subcutaneous
Gut-focused referenceAmount: Per formulationFrequency: DailyRoute: Oral

Observed effects timeline

Aggregated observations reported across research literature. Timing and magnitude vary by model and are not a guarantee of outcome.

  1. Week 1–2

    Onset of anti-inflammatory signaling reported in gut/skin research models.

  2. Week 4+

    Sustained inflammation-modulating effects reported with continued use.

Research compatibility

Describes how compounds are studied alongside one another in the literature. Not a recommendation to co-administer.

BPC-157

Frequently co-studied for gut-healing and anti-inflammatory pathways.

Synergistic

LL-37

Complementary host-defense/anti-inflammatory signaling.

Synergistic

Thymosin Alpha-1

Distinct immune-modulating mechanism.

Compatible

TB-500

Both have anti-inflammatory properties through different pathways - may work well together

Compatible

Melanotan II

KPV is derived from a-MSH like MT-II but without tanning effects - using both is unnecessary

Use caution

GHK-Cu

Excellent combination for skin health - GHK-Cu promotes collagen while KPV reduces inflammation

Synergistic

How to reconstitute

Important

Reconstitute with bacteriostatic water, swirl gently, and refrigerate. Avoid shaking to preserve the peptide.

  1. 1Allow the vial to reach room temperature (15–20 minutes).
  2. 2Swab the stopper with alcohol and let it air dry.
  3. 3Add bacteriostatic water slowly down the vial wall.
  4. 4Swirl gently until dissolved into a clear solution.
  5. 5Refrigerate at 2–8 °C and protect from light.
Open reconstitution calculator

Quality indicators

Uniform white powder

Lyophilized cake should be white to off-white without discoloration.

Clear solution

Reconstitutes to a clear, colorless, particle-free solution.

Cold-chain integrity

Reconstituted solution requires 2–8 °C storage.

Slight clumping

Small clumps that dissolve completely with gentle swirling are acceptable — shipping can cause minor compaction.

Collapsed or melted appearance

Powder that looks collapsed, melted, or stuck to the vial walls may have been exposed to heat in transit.

Cloudy after reconstitution

Persistent cloudiness, particles, or precipitate after gentle mixing can indicate a degraded or contaminated peptide.

Reported observations & safety

Safety signals reported in the research literature. Compiled for scientific awareness — not medical advice.

  • Generally reported as well tolerated; mild injection-site reactions are the most common signal.
  • Unlike full alpha-MSH, it does not stimulate pigmentation.

References & further reading

KPV tripeptide anti-inflammatory activity (review)

Preclinicalalpha-MSH fragmentgut/skin

Review of the KPV tripeptide's anti-inflammatory actions in intestinal and dermal research models.

View study

Topics

anti-inflammatorygutimmune

This entry is provided for educational and informational purposes only. It is not medical advice, a dosing protocol, or a claim of therapeutic benefit. Research compounds are supplied strictly for laboratory and research use — not for human or veterinary consumption.

Research level
Emerging Research

Active but early-stage research; evidence still developing.

Quick reference
Dose range200–500 mcg daily (research models)
RouteSubcutaneous / oral / topical
DurationDaily, multi-week studies
Storage2–8 °C reconstituted
Half-life~Short (hours)
Catalogue status

This compound is part of our educational reference and is not currently stocked. Browse the catalogue for available research-grade peptides.

Browse catalogue